UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Journal of dermatological science, 2016-03, Vol.81 (3), p.153-164

2016

Volltextzugriff (PDF)

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Journal of the American Academy of Dermatology, 2021-07, Vol.85 (1), p.71-78

2021

Volltextzugriff (PDF)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Allergy (Copenhagen), 2022-08, Vol.77 (8), p.2555-2558

2022

Volltextzugriff (PDF)

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis

British journal of dermatology (1951), 2023-01, Vol.188 (1), p.146-148

2023

Volltextzugriff (PDF)

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

Journal of dermatological science, 2014-08, Vol.75 (2), p.133-139

2014

Volltextzugriff (PDF)

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study

Allergy (Copenhagen), 2023-07, Vol.78 (7), p.1964-1979

2023

Volltextzugriff (PDF)

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.3335-3337.e1

2022

Volltextzugriff (PDF)

Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Journal of the European Academy of Dermatology and Venereology, 2024-07

2024

Volltextzugriff (PDF)

Multispectral imaging of hand eczema

Contact dermatitis, 2019-12, Vol.81 (6), p.438-445

2019

Volltextzugriff (PDF)

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis

Experimental dermatology, 2015-03, Vol.24 (3), p.187-193

2015

Volltextzugriff (PDF)

Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis

Journal of dermatological science, 2017-12, Vol.88 (3), p.330-338

2017

Volltextzugriff (PDF)

Anti‐inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone

British journal of clinical pharmacology, 2018-08, Vol.84 (8), p.1719-1728

2018

Volltextzugriff (PDF)

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Journal of the American Academy of Dermatology, 2023-04, Vol.88 (4), p.816-823

2023

Volltextzugriff (PDF)

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years

Allergy (Copenhagen), 2024-06, Vol.79 (6), p.1560-1572

2024

Volltextzugriff (PDF)

Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy

Archives of Dermatological Research, 2014-10, Vol.306 (8), p.719-729

2014

Volltextzugriff (PDF)

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Journal of drugs in dermatology, 2013-08, Vol.12 (8), p.e129

2013

Volltextzugriff (PDF)

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

Journal of dermatological science, 2017-02, Vol.85 (2), p.147-147

2017

Volltextzugriff (PDF)

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Anticancer research, 2014-12, Vol.34 (12), p.7207-7217

2014

Volltextzugriff (PDF)

Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model

Journal of translational medicine, 2009-12, Vol.7 (1), p.107-107, Article 107

2009

Volltextzugriff (PDF)

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.957-958

2014

Volltextzugriff (PDF)

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

Dermatitis, 2015-07, Vol.26 (4), p.195-196

2015

Volltextzugriff (PDF)

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

Skin research and technology, 2021-09, Vol.27 (5), p.715-722

2021

Volltextzugriff (PDF)

The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges

Experimental dermatology, 2017-10, Vol.26 (10), p.926-933

2017

Volltextzugriff (PDF)

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB198-AB198

2023

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Multispectral imaging of hand eczema

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis

Effects of glucocorticoids on stratum corneum lipids and function in human skin—A detailed lipidomic analysis

Anti‐inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years

Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophy

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Aktive Filter

Suchergebnisse filtern